NuVasive launched three new biologics offerings for the spine industry.
The newest product lines are:
1. Traditional bone allograft, featuring cancellous chips, demineralized cancellous chips, cortical cancellous chips and cancellous crushed. The allograft can be packed into bony voids or gaps in a patient's skeletal system and is available in several grind sizes and volumes.
2. Amniotic membrane DS, a double-sided layer of human amniotic membrane designed to be a biologic barrier to help prevent adhesions and reduce scar tissue formation near adjacent muscle, nerve and fascia layer tissue.
3. Additional form factors to the Propel DBM product line, which now includes gel, gel plus and putty plus as additional form factors with enhanced handling properties. The additional DBM form factors are intended to enable surgeons to tailor graft selection to the patient's needs.
NuVasive's newest biologic product lines are intended to improve patient outcomes and economic outcomes for hospital systems as well as meet spine surgeon's handling preferences.